Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: “All that glitters is not scleroderma renal crisis”
Renaud Felten(Centre National de la Recherche Scientifique), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Joëlle Goetz(Hôpitaux Universitaires de Strasbourg), Éric Prinz, Emmanuel Chatelus(Laboratoire National de Référence), Laurent Arnaud(Université Libre de Bruxelles), Benoît Nespola(Hôpitaux Universitaires de Strasbourg), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Matthieu Canuet(Université de Strasbourg)
Cited by 3
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355